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ABSTRACT 
The incidence of IgG subclass deficiency has been well documented in the Westem 
World. Li a study of 8015 healthy blood donors, 4% were found to be deficient in 
IgG2 subclass. No local information is available on this disease entity. IgG subclass 
deficiency though presented with recurrent sinopulmonary infections and otitis 
media, can easily escape the first line clinical and laboratory investigation especially 
in the health care system in Hong Kong when patients are not cared by their family 
doctor. 
The Beckman Array 360 Protein System is an analyser utilising the principle of rate 
nephelometry to quantify protein in biological fluid. The Binding Site IgG Subclass 
Array Kit has been optimised for the Array 360 Protein System. A study was 
conducted to evaluate the performance of The Binding Site IgG subclass assays on 
the Array 360 Protein System. A pilot study was conducted on 53 patients with 
recurrent infections, bronchiectasis and otitis media together with 26 control 
subjects. 
Evaluation of the IgG subclass assays demonstrated within-batch CV of 0.6% to 
1.90/0 and inter-assay CV of 1.4% to 4.3%. Lowest limits of detection for the four 
subclasses are 1494mg/L, 318mg/L, 108mg/L and 132mg/L for IgGl, IgG2, IgG3 
and IgG4 respectively. These performance characteristics are within that claimed by 
The Binding Site. The assays are easy to perform and a panel of four IgG subclasses 
can be performed in approximately three minutes once the instrument is running. 
The laboratory study did not reveal any case o f IgG subclass deficiency in the patient 
group. IgGl and IgG3 of patients were significantly higher than that of the control 
group by Mann Whitney U test with both p values of <0.005. Therefore in the 
context of IgG subclass deficiency, there was no difference between the patient 
group and control group. IgG2 levels of patient with bronchiectasis also showed no 
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CHAPTER 1 
• R O D U C T I O N 
1 
1.1 Overview 
Five major classes of immunoglobulins are normally present in blood. Clonal 
expansion of B-lymphocytes, upon recognition of a foreign antigen, differentiates 
into plasma cells, bnmunoglobulins are produced by plasma cells. 
All immunoglobulin molecules consist o f a basic unit o f two identical heavy (H) and 
two identical light (L) chains joined by disulfide bonds (Figure 1.1). There are two 
types of L chains and five classes of H chains. They differ from each other in 
antigenicity, carbohydrate content and also in size. 
There are also expressed several heavy chain subclasses of immunoglobulins. Four 
subclasses of immunoglobulin G (IgG), namely IgGl, IgG2, IgG3 and IgG4 and two 
subclasses of immunoglobulin A (IgA), namely IgAl and IgA2 had been found. The 
immunoglobulin subclasses have approximately 95 % structural homology with other 
subclass molecules of the same immunoglobulin type but significantly different from 
that of the other immunoglobulin isotypes. 
1.2 Historical perspective 
IgG subclasses were discovered in 1960 [1] but it was not until 1964 [2] that their 
existence became recognized. Most of the investigations used myeloma proteins due 
to their monoclonal nature, available with high purity and in high concentrations. 
In 1960, Dray [1] immunized rhesus monkey with normal serum y-globulins 
(essentially IgG) prepared by cellulose ion-exchange chromatography. The 
harvested antisera, when used natively and after absorption with different myeloma 
proteins, were used for immunoelectrophoresis studies. On immunoelectrophoresis, 
antibodies directed against three different proteins (designated y-A, y-B and y-C) of 
the Y -globulins were demonstrated. Another group of researchers [2] carried out an 
investigation similar to that of Dray's. Essentially, they demonstrated three 
2 
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A simplified model of a human IgGl immunoglobulin molecule, showing the basic 
four-chain stnicture and domains (depicted as loops). V = variable region; C = 
constant region; L = light chain; H = heavy chain. Thick lines represent immuno-
globulin chains; thin lines with "SS" represent disulfide bonds. The Fab (antigen-
binding) portion of the molecule is to the lcfl of the two disulfide bonds between 
heavy chains, in the hinge region of lhc molecule. It includes the antigen-binding 
sites formed by the variable regions of light and heavy chains. The Fc portion of 
the molecu!e, to the right of the hinge region, gives the molecule certain biologic 
activities, including Fc receptor binding, placental transfer, serum half-life, and abil-
ity to fix complement. 
Figure 1.1 An immunoglobulin molecule (From Smith TF. IgG subclass. Adv 
Pediatrl992;39:102) _ 
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Another group of researchers [2] carried out an investigation similar to that of 
Dray's. Essentially, they demonstrated three precipitin arcs (designated as y^ "^, y^ '^ 
and /c-giobulins) on immunoelectrophoresis of normal human serum with the 
harvested antiserum. Further investigations were carried out to elucidate the 
properties of the protein that the antibodies were directed against. Normal human 
serum and serum from thyroiditis patients were used. They demonstrated that the 
protein arcs precipitated from the thyroiditis serum specifically bind 1^ ^^  labeled 
thyroglobulin, binding was not observed in the normal human serum control. This 
suggested that the antiserum raised from immunising rhesus monkey with y-globulins 
produced antibodies directed against antibody molecules in human serum. The 
location of the antigenic determinant within the y-globulin molecule was 
investigation by Ouchterlony analysis after reductive cleavage of the y-globulins. It 
was demonstrated that the antibodies produced were directed against the heavy 
polypeptide chain of the IgG molecules. 
Grey et al. [3] used a variety of antisera directed against isolated myeloma proteins 
and successfully distinguished that there are four subgroups o f7S y-globulins. 
These studies [1,2,3] paved the milestones to the discovery and classification of the 
four IgG subclasses. 
1.3 Biochemistry of the IgG subclasses 
The four subclasses of IgG in human are designated IgGl, IgG2, IgG3 and IgG4 
(Figure 1.2). Their amino acid sequences showed more than 95% homology [4]. 
Some biological properties of the IgG subclasses are shown in Table 1.1. 
The most notable difference between the four subclasses is that IgG3 is heavier than 
the three other subclasses. The heavier IgG3 is attributed to the presence of 
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Figure 1.2 Diagrammatic representation of the four IgG subclasses. (From 
Immunology Today, July 1980) 
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Subclass IgGl IgG2 IgG3 IgG4 
Heavy chain yl y2 y3 ^ 
Half-life ( d a y s ) ~ ~ ^ ^ 9 ^ 
Molecular 146,000 146,000 165,000 146,000 
weight 
Complement ++ + +++ ~ 
fixation 
Placental + 土 + "+ 
transport 
Table 1.1 Physicochemical and biological properties of IgG subclasses [5] 
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shortest half-life among the four subclasses and bear the most disulfide bond in the 
hinge region. IgGl, IgG2 and IgG3 fix complement to varying extent while IgG4 is 
unable to fix complement. Transfer of IgG subclasses across placenta confers 
immunity to the neonate immediately after parturition [5]. 
1.4 IgG subclasses and human diseases 
IgG subclasses had been studied in diseases in which there is an involvement of 
immunological components. Diabetes mellitus, systemic lupus erythrematosis, 
glomerulonephritis, skin lesions such as pemphigus are only a few to name in which 
there is an imbalance of IgG subclasses. IgG subclasses in primary antibody 
deficiency syndrome will be discussed in later section. 
1.4.1 Glomerulonephritis 
Imai et al. [6] studies the role of IgG subclasses in membranoproliferative 
glomerulonephritis (MPGN), membranous nephropathy (MN) and lupus nephritis 
(LN) and suggested "IgG subclass determines the phenotype of glomerulonephritis". 
Difference in serum concentrations as well as glomerular depositions of IgG 
subclasses varied among the three conditions. Glomerular deposition of IgGl and 
IgG2 were found in significant amount in LN. IgG3 and IgG4 were respectively 
found to be associated with MPGN and MN. 
1.4.2 Blistering skin lesions 
Bullous pemphigoid (BP), pemphigus vulgaris (PV) and pemphigus foliaceus (PF) 
are autoimmune diseases resulting in blistering of the skin. These conditions are 
characterised by circulating IgG autoantibodies against intracellular substance (ICS) 
and basement membrane of the epidermis. 
Jones et al [7] demonstrated a restriction of IgG subclass to intracellular substance 
within IgGl and IgG4. Kumar et al. [8] has recently demonstrated that IgG basement 
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membrane autoantibody was primarily of IgG4 subclass and is present in all BP 
cases. The use of subclass specific antiserum will significantly improve on the 
diagnostic efficiency of the immunofluorescence test. 
1.4.3 Insulin dependent diabetes mellitus (IDDM) 
IgG circulating islet cell autoantibodies (ICA) are the serological marker in IDDM. 
Lti a study of 51 IDDM patients [9], all of them had IgGl ICA. A significant 
difference was observed between patients with IDDM only from those IDDM 
patients presented with thyro-gastro autoantibodies in that the latter group 
demonstrated higher concentrations of IgG2, IgG3 and IgG4 ICA. The co-
occurrence of IgG ICA of other subclasses in patients with multiple organ 
autoimmunity suggested a more heterogeneous clonal recruitment pattern. 
1.5 Primary antibody deficiencies 
A range of primary antibody defects has been recognised and classified as shown in 
Tablel .2[10] . 
1.5.1 CVID 
CVED represents a "conglomeration of as yet undifferentiated syndromes" 
characterised by defective antibody production diagnosed based on exclusion of 
other defects. Decreased IgG and IgA subclasses followed the order of the heavy 
chain constant region coding sequences on chromosome 14 with isotypes further 
downstream being more affected; thus the presentation of variable deficiency of 
immunoglobulin M (IgM) together with decreased IgA and IgG. [11] 
1.5.2 X-linked antibody deficiency 
Serum immunoglobulins are low and mature B-cells are absent. The defect is caused 
by mutations in the Bruton's tyrosine kinase (Btk) gene. Absent of functional Btk 
leads to failure ofB-cell differentiation. [11] 
8 
Types ofprimary antibody deficiencies 
• Common variable immune deficiency (CVID) 
• X linked antibody deficiency 
• IgG subclass deficiencies 
• Specific antibody deficiency 
• Selective IgA deficiency 
Table 1.2 Classification of primary antibody deficiencies [10] 
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1.5.3 IgG subclass deficiency 
Criteria for diagnosis is based on a normal IgG level with subnormal or low level of 
one or more subclasses. Mostly resulted from failure in terminal differentiation of B 
cells [11]. Deletion of genes cluster coding for the IgG heavy chain had been 
reported [31,32,33]. 
1.5.4 Specific antibody deficiencies 
The criteria for diagnosis of specific antibody deficiencies include demonstration of 
an inability to respond to some antigens but normal response to other antigens. 
Usually total IgG and IgM levels are normal. Association with IgG2 deficiency had 
been reported. [11]. 
1.5.5 Selective IgA deficiency 
Selective IgA deficiency is prevalent among Caucasians with an occurrence of 1:700. 
The defect is presumed to be maturational failure of IgA producing lymphocytes. 
Frequently associated with IgG subclasses deficiencies. [11] 
1.6 IgG subclasses deficiency 
IgG subclasses deficiency, in its own represent a type of primary antibody 
immunodeficiency syndrome. However, deficiency of IgG subclasses is invariably 
associated with other primary antibody deficiency as well as secondary immune 
deficiency. 
In a retrospective study, 4% out of3005 patients studied were found to suffered from 
selective IgGl deficiency [12]. This condition had in the past been confused with 
CVU). Clinically, 83 percents of these selective IgGl patients were presented with 
moderate recurrent infection predominately of the upper respiratory tract. 
Patients suffering from ataxia telangiectasis - "a severe hereditary progressive 
cerebellar ataxia, transmitted as an autosomal recessive trait, and associated with 
10 
oculocutaneous telangiectasia, abnormal eye movements, sinopulmonary disease, 
and immunodeficiency" [13] — were reported to have significantly decreased or even 
undetectable IgG4 subclass. Out of the 23 (92%) patients who had IgG4 deficiency, 
only 3 had concurrent IgG2 deficiency [14]. Very low or borderline low IgG2 levels 
were found in 22 ataxia-telangiectasia patients studied and 19 out of 22 had 
undetectable IgG4 in their serum [15]. 
Lti a study of 73 patients, predominantly children with IgA deficiency [16], 27 
patients were found to have IgG subclass deficiencies. Among the 27 patients, 12 of 
them demonstrated isolated IgG4 deficiency. The remaining 15 had either isolated 
deficiency of other subclasses or IgG4 in combination with other subclasses 
deficiency. All patients studied had problems associated with the respiratory tract. 
Impaired lung function was found to correlate significantly with low IgG2 and IgG3 
levels among a group of 29 patients with IgA deficiency [17]. A suggestion that a 
causal relation exist between low IgG2 or IgG3 levels and impaired lung function 
was put forward. In fact, the conditions of some patients had benefit from 
immunoglobulin prophylaxis. 
1.7 Clinical Manifestation of IgG subclass deficiency 
Schur et al. [18] described three patients with the recurrent episodes of otitis media, 
sinopulmonary infections and progressive pulmonary diseases who were 
subsequently diagnosed to be deficient in one or more IgG subclasses. These 
patients present with low IgGl and combinations of IgG2, IgG3 and IgG4 
deficiencies. Their infections responded well to antibiotic therapy. Recurrent 
infections were prevented upon prophylactic gamma globulins replacement therapy. 
Recurrent bronchitis, which the investigators [19] defined as "three or more episodes 
a year, during 2 consecutive years, of bronchopulmonary infection, productive cough 
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with or without fever and/or diffuse rales by physical examination in the absence of 
asthma or atopy" is one common clinical presentation of IgG subclass deficiency. 
Among the 53 children who fulfilled the selection criteria, 30 of them presented with 
one or more subclasses deficiency, hi their study, the incidence of isolated subclass 
deficiency decreased in the order IgG4 > IgG3 > IgG2. 
]n another study [20], 7 out of 30 children suffering from recurrent infections had 
IgG2 deficiency. Only two of these 7 children had isolated IgG2 deficiency. The 
other 5 had combined deficiency with IgG4 and/or IgA. One of them also suffered 
from abnormal T cell function. These seven patients suffered from recurrent 
pneumonia, sinusitis, otitis media, invasive Haemophilus influenzae type b (Hib) 
infections, as well as severe pneumococcal meningitis. 
"The clinical hallmark of IgG subclass deficiencies are RECURRENT respiratory 
tract infections, including chronic sinusitis, otitis, relapsing pneumonia and 
bronchiectasis" [21] effectively summarised the presentation of patients suffering 
from IgG subclass deficiencies. The key word in the statement is the word 
RECURRENT which illustrate in entire the phenomenon that these patients cannot 
mount an effective secondary immune response on repeated exposure to the same 
causative infectious agent. 
1.8 Restriction ofIgG subclass responses to exogenous antigens 
h\ human, IgG subclass response induced by foreign antigens depends on the nature 
of the challenging antigens. It had been documented that challenge by 
polysaccharides and protein antigens elicit different antibody response. 
Hammerstrom et al. [22] demonstrated that specific IgG subclass antibody to alpha-
toxin, a protein toxin ofStaphylococcus aureus (S. aureus) was IgGl with substantial 
amount in IgG4. Complement fixing antibodies against Streptococcal M-associated 
12 
protein (MAP) were found not to be absorbed by protein-A-positive S. aureus [23]. 
This complement fixing antibody was later found to be of IgG3 subclass and 
correlated with the properties of this subclass in that it does not interact with protein 
A. 
Umetsu [24] studied the response to Hib capsular polysaccharide antigen in 20 
children with selective IgG subclass deficiency and recurrent sinopulmonary 
infections. IgG2 subclass deficient patients had lower anti-Hib capsular 
polysaccharide levels while IgG3 deficient patients and control subjects had normal 
concentrations. To eliminate the possibility of underexposure to Hib polysaccharide 
(CHO), immunisation of the study subjects with Hib vaccine showed that antibody 
response to Hib CHO in the IgG2 subclass was significantly lower in IgG2 deficient 
patients compared with IgG3 deficient patients and normal controls. The observation 
was in line with that of Siber [25] who demonstrated that antibody response to 
bacterial polysaccharide antigens resides within the IgG2 subclass. 
Specific antibody response towards teichoic acid, a carbohydrate antigen of S. aureus 
was demonstrated to elicit a response preferentially restricted to IgG2 subclass [22]. 
Within individual IgGSc antibody response to ovalbumin, avidin and pneumococcal 
polysaccharide was investigated by Lim and Lau [26] in the light that previous 
reported IgGSc responses to protein and pneumococcal antigen based on data from 
different subjects. They demonstrated that with ovalbumin, an association exist 
between IgG2 and IgG4 and between IgGl and IgG3. The antibody response to 
pneumococcal antigen is by and large similar to that investigation by Freijd et al. 
[27] Avidin which is a protein however in terms of its specific IgGSc antibody 
response, resembles pneumococcal antigen to a larger extent. This suggested that the 
13 
carbohydrate moiety of the glycoprotein may be more immunodominant or that the 
protein fraction is more easily degraded. 
1.9 Expression ofIgG subclasses 
Two hypotheses on B-cell isotype switching had been proposed. A single lineage 
model and a multilineage model had been proposed. (Figure 1.3) 
The single lineage model suggested that a single B cell could express all heavy chain 
isotypes of immunoglobulins with the same V region by the order of the genes on 
chromosome 14 [28,29]. 
In human, IgG2, in which the coding sequence is further down the chromosome, had 
been demonstrated to secrete preferentially in response to polysaccharide antigen 
challenge. In addition, exceptions to this IgG2 restriction had been demonstrated in 
response to Haemophilus influenzae b polysaccharide and pneumococcal capsular 
polysaccharide. Nahm et al [30] demonstrated that V region of IgG2 antibody 
against phosphocholine (an immunodominant antigen in the carbohydrate cell wall of 
Streptococccus pneumoniae) bound phosphocholine (PC) irrespective whether it is 
conjugated to protein carrier or as carbohydrate antigen. On the contrary, IgGl 
antibody will bound only PC antigen conjugated to protein only. Nahm et al. 
suggested that "certain V regions preferentially pair with certain IgG subclasses and 
supports the multiple B cell lineage model". 
1.10 Mechanisms ofIgG subclasses deficiency 
1.10.1 Gene deletion 
The immunoglobulins heavy chain genes are located on chromosome 14. (Figure 1.4) 
Gene deletion of the immunoglobulin heavy chain cluster had been identified in the 
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Figure 1.3 Two hypothetical but contrasting models of B cell development (From 
Nahm MH, Scott MG, Shackleford PG. Expression of human IgG subclasses Ann 
Clin Lab Sci 1987; 17:185) ‘ 
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Schematic representation of the human Immunoglobulin heavy-chain gene locus. 
The upper panel shows that genes encoding heavy chain variable (V^ )^ regions, di-
versity (D„) regions, and joining («]„) regions of the antibody molecule are located 
toward the 5' end of the chromosome, followed by genes encoding the constant 
{Cn) domains toward the 3' end. Each C^ gene encodes three constant domains. 
Switch regions are located to thc 5' side of each Cn gene. The first DNA rear-
rangement assembles one • „ gene, one Dn gene, and one J^ gene, to complete 
the variable portion of the molecule. Association of this VDJ segment with the ad-
jacent Cp> gene promotes transcription of complementary messenger RNA for pro-
duction of cytoplasmic p, chains. The lower panel illustrates a second DNA rear-
rangement involving switch sites that may result in a more distant C " gene, such as 
Cy2, moving next to the rearranged VDJ segment, as in an IgG2-secreting cell. 
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Figure 1.4 Schematic representation of the human immunoglobulin heavy-chain 
gene locus (From Smith TF. IgG subclass. Adv Pediatr 1992; 39:103) 
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technique [31]. This Tunisian Berber presented with a simultaneous absence of 
IgGl, IgG2, IgG4 and IgAl resulted from the multigene deletion. 
Chaabani et al. [32] identified another deletion in the immunoglobulin heavy chain 
that includes the alpha-1, gamma-2 and gamma-4 region in one o f32 random Arabo-
Berber Tunisian analysed. Other multigene deletions had been reported including an 
alpha-1, gamma-2, gamma 4 and epsilon found in Sardinian. A similar alpha-1, 
gamma-2, gamma 4 and epsilon gene deletion was reported in a pair of siblings by 
Plebani et al. [33] in Itlay. The pair of siblings is offspring from a heterozygous 
father carrying the A1 to E gene deletion and a heterozygous compound mother 
having deletion in one chromosome but duplication in the other. 
In individuals with gene deletions, the overall susceptibility to infections may not be 
increased. In the earliest study on Tunisian Berber, the subject was healthy [31] 
The health status of the subject in Chaabani's [32] study was not mentioned. h\ the 
study by Plebani [33], the two siblings were presented with minor upper respiratory 
infections. On immunisation of these two siblings with tetanus toxoid and 
polysaccharide antigens, the IgGl and IgG3 responded to a greater extent when 
compared with response in all four subclasses in control subjects. 
1.10.2 Immune dysreguIation 
Immune regulatory cells and substances have a role to play in IgG subclass 
deficiency. B-lymphocytes requires the co-operation of immune regulatory T-
lymphocytes and cytokines to function properly. The role of immune regulatory 
cells and substances on IgG subclasses production were largely obtained through in 
vitro experiments on cells isolated from subclasses deficient or normal individuals 
17 
1.10.2.1 T-cell receptor defects 
A link between T cell receptor (TcR) expression defect and IgG2 deficiency as well 
as poor antibody response to polysaccharide antigens was investigated by Regueiro 
et al. [34] in a pair of siblings. Both children suffered from TcR immunodeficiency. 
Antigen challenge by endogenous and exogenous proteins revealed normal immune 
response. An impaired response was however noted to polysaccharides antigens 
with IgG2 deficiency. An abnormal T cell receptor was found to be expressed on 
one of the two siblings studied. The investigators suggested that "the low number of 
peripheral T lymphocytes that have been found to express low TcR levels in these 
immunodeficiencies may be operational, and supplying sufficient ‘help’ for the 
observed normal antibody responses to all tested protein, but not polysaccharide 
antigens". 
1.10.2.2 Interferon gamma (IFN-y) 
Inoue et al [35] studied on the effect of defective interferon gamma production on 
IgG2 subclass deficiency. Two pairs of siblings suffering from IgG2 deficiencies 
were studied. Familial study showed that patients and family members all have 
sufficient number of immune cells (including) CD3+, CD4+, CD8+and CD14+ as 
well as CD16+ cells. Response of patients peripheral blood mononuclear cells 
(PMBC) to phytohaemagglutinin or concanvalin A (Con A) were normal but 
interferon gamma production was significantly lower than control subjects 
Interleukin-2 production by PMBC upon stimulation by Con A was normal in all 
four patients. When PMBC were stimulated with pokeweed mitogen (PWM) in the 
absence or presence of interferon gamma, significant elevation in IgG subclasses 
secretion was observed in the latter. Hioue et al. suggested that "the dysfunction in 
the production ofIFN-gamma plays an important role in IgG2 deficiency." 
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1.10.2.3 Inteleukin-4 (IL-4) 
Inteleukins-4 was suggested to regulate IgG subclass in two different ways by 
Kotowicz et al. [36]. IgG subclass production by Epstein Barr virus - T-cell 
independent polyclonal B cell mitogen -- activated B cells were found to behave 
differently in the presence of different concentration of IL-4. At a low concentration 
(5 U/mL), IgGl, IgG2 and IgG3 were produced whereas IgG4 production was 
induced by IL-4 at a significantly higher concentration (100 U/mL) suggesting the 
existence of a high- and low- affinity activation pathway for IL-4 mediated B-cell 
activation. 
1.10.2.4 Interleukin-6 (IL-6) 
The role ofIL-6 in the regulation of IgG subclass production was studied by Kawano 
et al. [37]. Lti vitro study demonstrated the presence of IL-6 at various stage of the 
PBMC culture resulted in enhancement of different IgG subclass production. The 
main action ofIL-6 is on the differentiation of committed B cells and triggering o fT-
helper activity. 
1.11 Prevalence ofIgG subclass deficiency 
In 1988, a study was carried out to study IgG2 deficiency among 8015 blood donors 
[38]. Among these 8015 healthy blood donors, a total of 312 had IgG2 
concentrations of lower than 1.3 g/L (2SD below the mean). This suggested that 4% 
of healthy individuals who satisfy the criteria of the respective blood transfusion 
authority for fitness ofblood donation had IgG2 deficiency. 
Chapel reported for the Consensus Panel for the Diagnosis and Management of 
Primary Antibody Deficiencies [39] that according to Swedish data on prevalence 
[40], the British register of primary immune deficiencies included only 40% of 
affected patients. Furthermore, a diagnostic delay of2 .5 and 5.5 years was noted for 
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CVID in children and adults respectively suggesting a poor awareness of the 
condition. 
1.12 Reference intervals for IgG subclass 
The ontogeny of the four IgG subclasses does not go in parallel. Serum IgGl and 
IgG3 levels reach adult concentrations earlier whereas IgG2 and IgG4 levels achieve 
adult concentrations at around 10 to 12 years old [41,42]. 
A study was conducted in 1994 by Lau et al. [43] to construct percentile range for 
serum IgG subclasses in healthy Hong Kong Chinese children. The major two 
subclasses IgGl and IgG2 were found to increase until the age of 13 and 18 
respectively. IgG4 demonstrated the same wide variation in range as had been 
demonstrated in other studies [42,44] and the phenomenon that a substantial 
proportion of the studied subjects had undetectable IgG4 [42,45]. 
1.13 Methods for investigation ofIgG subclass deficiency 
The methodologies for quantification of IgG subclasses are essentially similar to 
those available for the quantification of other immune proteins in serum. However 
the marked difference in IgG subclass concentrations ranging from the predominant 
fraction IgGl to the subclass of lowest concentration, namely IgG4 necessitate 
careful optimisation of the assays. 
Different immunoassay methods are available for the quantification of IgG 
subclasses in human serum. Methods available ranges from radial-immunodiffusion 
enzyme linked immunosorbent assay (ELISA) as well as more automated procedures 
such as nephelometry and turbidimetry. All these methods require the use of anti-
subclass antibody preparations. Monoclonal antisera, and polyclonal antisera render 
monospecific are available. In addition, the availability of a WHO immunoglobulin 
Reference Preparation 67/97 [46] served as a consensus to standardisation of assays 
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using different approach. Assays calibrated against this the reference preparation 
should exhibit less inter methodology variation in results reported. 
1.13.1 Radial-immunodiffusion 
Radial immunodiffusion is by far the most popular method used among investigators 
studying IgG subclasses [24,43]. The principle is by incorporating the subclass 
specific antisera in agarose and poured onto a thin layer in a plate. Wells are 
punched on the gel and accurate quantity of sample are added into the wells and 
allowed to diffuse radially at room temperature. At the equivalent point of antigen-
antibody reaction, an intense precipitin ring will be formed. 
1.13.2 Enzyme linked immunosorbent assay 
This is usually carried out in microtitre plates. The wells o f the microtitre plates are 
coated with subclass specific antibody and unoccupied binding sites are blocked by 
albumin. Samples are incubated in the wells and IgG subclass will be bound to the 
solid phase. The next step is to wash away the unbound serum sample in the wells, 
leaving behind the antibody bound IgG subclasses. A tracer linked second antibody 
directed against the human IgG subclass molecules but not reactive toward the 
capturing antibody is then added. In EIA, the most common tracers are enzyme 
labels such as horseradish peroxide or alkaline phosphatase. The absorbance 
developed upon addition of substrate is proportional to the concentration of IgG 
subclass. 
1.13.3 NepheIometry/turbidimetry 
Turbidimetry and nephelometry quantify IgG subclass concentrations by mean of 
blocking of incident light and scattering of incident light respectively. Precipitated 
immune complex in solution will scatter light to varying extent. The higher the 
concentration of the analyte under consideration, the greater the scattering or the less 
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the transmitted light. These assays are rarely used as endpoint assays and in 
automated analysers, usually the parameter recorded is the rate of change ofturbidity 
or light scattering. 
1.14 Aim of study 
IgG subclass deficiency is a primary antibody deficiency which will be easily missed 
in the routine investigation of patient when the most common investigation 
performed is a serum immunoglobulins pattern. In IgG subclass deficiency, the 
serum total IgG can fall within the normal range. Therefore IgG subclass deficiency 
can be present despite a normal total IgG level, ln view of this situation, the current 
study is undertaken to: 
1. investigate on the performance characteristic of The Binding Site IgG Subclass 
Beckman Array 360 assays; and 
2. investigate on the prevalence of IgG subclass deficiency among patients with 
recurrent respiratory infections, bronchiectasis and other lung diseases as well as 
otitis media. 
Part 1 of the study is on analytical biochemistry and part II of the study is on the 
biochemical basis of disease. 
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CHAPTER 2 
MATERIALS AND METHOD I 
The Binding Site IgG Subclass Assay 
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2.1 Materials 
2.1.1 IgG subclass assay 
The following reagent was obtained from The Binding Site through TWC Research 
Limited, Hong Kong 
- Human IgG subclass Beckman Array kit (Product code: NKOO1 .E) 
The kit contains calibrator set, controls and four bottles of antiserum, one for 
each subclass. 
The following reagents were required for running the IgG subclass assays on 
Beckman Array 360 and were obtained from Beckman bistruments (H.K.) Limited 
- Array buffer (Product code: 663600) 
- Array diluent (Product code: 663630) 
2.1.2 Evaluation of patients immune status 
The following reagents were obtained from The Binding Site through TWC Research 
Limited, Hong Kong 
- Total haemolytic complement kit (Product code: RCOO1.3) 
- Alternative pathway haemolytic complement kit (Product code: RC003.3) 
The following reagents were obtained from Beckman Instruments (H.K.) Limited 
- IgM assay (Product code: 446610) 
- IgG assay (Product code: 446600) 
- IgA assay (Product code: 446605) 
- C3 assay (Product code: 465330) 
- C4 assay (Product code: 465335) 
- PFB assay (Product code: 449450) 
2.1.3 Apparatus and equipment 
- Beckman Array 360 protein system 
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- The Binding Site jeweler eyepiece 
2.2 Evaluation of The Binding Site human IgG subclass assay on Beckman 
Array 360 protein system 
2.2.1 Principle of the Beckman Array Protein System 
The Beckman Array 360 protein system employs the principle of rate nephelometry 
to quantify specific proteins in biological fluids. 
When an antigen in serum is mixed with a specific antibody against it, antigen-
antibody binding will occur resulting in the formation of immune complex. At 
optimum antibody and antigen concentration and in the presence of polyethylene 
glycol, these immune complexes will aggregate to form large lattice and will scatter 
light. (Figure 2.1) The Array 360 analyser monitors the rate of change of light 
scattering which is proportional to the amount of analyte present in the biological of 
interest. 
Factors that can be varied to optimise an user-prep chemistry on Array 360 analyser 
include the gain setting of the analyser, concentration of the antibody and the dilution 
of the biological sample. 
2.2.2 Assay preparation and procedure 
Four IgG subclass assays designated G1, G2, G3, G4 were set up in the Array-360 as 
user-prepared chemistries (UPC). The parameters for calibration run and sample run 
are shown in Tables 2.1 and 2.2: 
From a comparison of Tables 2.1 and 2.2, the difference in UPC setup for calibration 
and sample (including control) lies in the dilutions used. Samples were assayed at a 
dilution six times more than that of the calibrators. Literally, this means that the IgG 
subclass concentration for plotting of the calibration curve is actually six times that 
was given on the bottle. The Binding Site refers to this value as the 'calibrator 
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Figure 2.1 Antigen-antibody reaction under varying concentrations of antigen and 
antibody (From Beckman Array 360 User Manual) 
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[ ^ i [ ^ r ^ [ ^ 
Gain S 33 ^ ^ 
Dilution 1:36 1:6 Neat 一 Neat 
Optics L R R L 
Table 2.1: User-prepared chemistry setup for calibration of IgG subclass assays 
\~Gi p 2 r ^ r ^ 
Gain ^ ^ ^ ^ 
Dilution 1:216 H ^ H6 H ^ 
Optics L R R L 
Table 2.2: User-prepared chemistry setup for IgG subclass sample assays 
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representative concentration'. Any sample assayed with the STANDARD sample 
dilution can be read off directly form a plot of rate against calibrator representative 
concentration. Any deviation in dilution used for the sample assays will require 
correction of the results with respect to the standard dilution. 
2.2.3 Performance characteristic of the IgG subclasses assay 
Investigations on the gain setting, precision, linearity, recovery and interference of 
the IgG subclass assays were performed. 
2.2.3.1 Gain setting 
The Binding Site IgG subclass kit used in this study is an optimised assay. No 
attempt was made in altering the antibody concentration and the sample dilution. 
The appropriateness of the instrument gain setting was verified by running the same 
sample using a gain setting 1 step higher and 1 step below that recommended by The 
Binding Site. 
2.2.3.2 Within batch precision 
Three levels of pooled human sera were prepared from a single pool. The high pool 
was prepared by thawing the frozen pool. The top more dilute layer was pipetted off 
to another pool for preparation of a low pool serum. The original pool was used as 
the medium pool. 
2.2.3.3 Interassay precision 
In this study, the low end of the assay range is the area of interest. Three levels of 
between run precision were studied by using the neat low control, and two other 
pools prepared by dilution of the low control with calibrator 8 that came with the 
reagent kit. 
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2.2.3.4 Linearity of the assay 
A pooled human serum sample was assayed for its four IgG subclass levels. The 
pooled sample was then concentrated to 1/3 its original volume by removing the 
serum water content by freeze drying technique. The resulting serum was separated 
into four different portions. Each portion was reconstitute to a volume such that the 
subclass concentration falls near to the top of the linearity claimed by The Binding 
Site. These sera were then doubling diluted and assayed to assess the linearity and 
detection limit of the assay. 
2.2.3.5 Interference of the IgG subclass assay 
Haemolysis 
A whole blood sample was washed ten times with saline to remove the entire plasma 
protein component. The packed red cells were suspended in limited amount of 
saline. The haemoglobin content of the saline suspended red cells was measured. 
The saline suspended red blood cells sample was frozen and thawed twice to prepare 
the haemolysate for interference study. 
A visually clear serum sample was spiked with the haemolysate. This served as the 
haemolysed sample. Another aliquot of the same serum sample was similarly spiked 
with reagent grade water. The IgG subclass concentrations of the two serum samples 
were assayed to assess the interference due to haemolysis 
Lipaemia 
The approach adopted was similar to that for haemolysis. A human serum with low 
endogenous triglycerides was spiked with Lipofundin, an W solution containing 
glycerol as well as triglycerides. h\ order to obtain the true concentration of 
triglycerides spiked, a triglycerides-glycerol blanked assay was set up on the 
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Beckinan Synchron analyser to measure the triglycerides content of the diluted 
Lipofundin solution. 
2.2.3.6 Recovery experiment 
Recovery experiment of the IgG subclass assays was conducted on two randomly 
chosen samples. Aliquots of these two samples were spiked with calibrator 1 and 
calibrator 5 of the IgG subclass assays calibrator set lot no 25395 using volumes 
according to Table 2.3 
The four recovery pools and the two neat samples were assayed in duplicates. The 
results obtained were used for recovery calculation. 
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Serum X (^iL) Serum Y (jaL) Calibrator 1 Calibrator 5 
_ (juL) 
Recovery pool 180 ^ 
X low 
Recovery pool 180 ^ ‘ 
X spiked high 
Recovery pool 180 ^ 
Y spiked low 
Recovery pool 180 ^ 
spiked high 
Table 2.3: Volume of sample and calibrator for preparation ofspiked samples for 
IgG subclass assays recovery experiment 
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CHAPTER 3 
MATERIALS AND METHOD II 
IgG Subclass Deficiency in Hong Kong 
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3.1 Patients and controls 
Fifty-three patients were recruited from Prince of Wales Hospital and Kwong Wah 
Hospital with recurrent sinopulmonary infections. Twenty-six controls were 
identified from colleagues and their relatives on the criteria that they did not suffered 
from recurrent infections, and had no recent infection. 
3.2 Blood samples 
A 7mL venous blood was collected from each patients and control subjects, and 
allowed to clot at room temperature for an hour. Serum was separated from the clot 
by centrifugation at 4°C for 15 minutes at 3000rpm. All samples were stored at 






Properdin factor B (PFB) 
Total haemolytic activity 
Alternative pathway haemolytic activity, and 
IgG subclasses 
Total IgG, IgA, IgM, C3, C4 and PFB were assayed on the Beckman Array 360 
Protein System using reagents manufactured by Beckman kistruments. Calibrations 
were made against Litemational Federation of Clinical Chemistry (IFCC) 
standardised value. For IgG subclasses, The Binding Site IgG subclass assays were 
performed on the analyser as user-prepared chemistries. 
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Control samples were assayed for total IgG and IgG subclasses. Tests for evaluation 
ofhumoral immune status were not performed on control samples. 
3.3 Serum total haemolytic complement and alternative pathway haemolytic 
complement assays. 
These were performed on the 53 patient samples using the respective assay kits 
obtained from The Binding Site 
3.3.1 Total haemolytic complement 
The principle behind the total haemolytic complement assay is one of radial 
diffusion. Serum complement components diffused radially into the gel containing 
antibody sensitised sheep red cells. The antibody, which serves as a heamolysin, 
fixes complement C1. At low temperature, C1 binds to the haemolysin. On 
incubation at 37°C, the classical complement pathway was activated resulting in lysis 
of the sheep red cell. The amount of active components in the serum is proportional 
to the square of the diameter of the lytic zone. Total haemolytic complement activity 
is expressed as CH100 units. 
3.3.2 Alternative pathway haemolytic complement 
Low level hydrolysis of C3 results in the formation of C3b molecules. When serum 
is added to the alternative pathway heamolytic complement assay gel. At 4 � C , C3b 
from the serum will diffuse radially into the gel and binds to the chicken erythrocytes 
in the gel allowing the formation of C5 convertase. Upon incubation at 37°C, the 
alternative pathway of the complement cascade will be activated leading to lysis of 
the chicken erythrocytes. The combined complement activity through the alternative 
pathway in the serum sample is proportional to the square of the diameter of the lytic 
zone. Alternative pathway complement lytic activity is expressed as % ofnormal. 
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These assays are supplementary to direct measurement of C3, C4 and PFB in a way 
that a normal level of these three measured parameters did not preclude deficiency of 
other complement components. The measurement of haemolytic activity required in 
the serum sufficient concentrations of all the components of the respective cascades. 
3.4 Statistical analysis 
Statistical analysis of data obtained on IgG subclass deficiency study was performed 
with Statistica for Windows version 4.2. Since patients and control subjects have 
been recruited at random, the non-parametric Mann Whitney U test was selected for 
analysis of data. 
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CHAPTER 4 
RESULTS I: Evaluation ofThe 
Binding Site IgG Subclass Array Kit 
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4.1 Gain setting 
The effect of varying the gain setting on the rate signal obtained for the four IgG 
subclass assays are shown on Table 4.1. The gain settings as recommended by The 
Binding Site were found to be appropriate for the antibody concentration used in the 
Array 360 kit. 
4.2 Within batch precision 
Within batch precision data are shown on Table 4.2. The coefficient of variation 
varied from the lowest of 0.6% to the highest of 1.9%. All these CV values were 
comparable if not better than those claimed by The Binding Site. 
4.3 Inter-assay precision 
Inter-assay precision data are shown on Table 4.3. The coefficient of variation 
varied from the lowest o f l . 4 % to the highest of 4.0%. On average, the CV values 
were comparable with that claimed by The Binding Site. 
4.4 Linearity and lowest limit of detection 
Linearity of the four subclasses assays were assessed by assaying doubling dilutions 
of the concentrated sample as described in section 2.2.3.4. Graphical representations 
of the linearity experiment results are shown on Figures 4.1-4.4. The lowest limit of 
detection were found to be 1494mg/L, 318mg/L, 108mg/L and 132mg/L for IgGl, 
IgG2, IgG3 and IgG4 respectively when assayed using the standard dilutions.. 
4.5 Interference experiments 
The effects of haemolysis and lipaemia on the IgG subclass assays were carried out 
as described in section 2.2.3.5. Results were tabulated on Tables 4.4 and 4.5. 
4.6 Recovery experiment 
Recovery experiments were carried out as described in section 2.2.3.6. The results 
are shown on Table 4.6. The range of recovery ranges from 94% to 114.6%. 
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Figure 4.1: IgGl Assay Linearity Plot 
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Figure 4.2: IgG2 Assay Linearity Plot 
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Figure 4.4: IgG4 Assay Linearity Plot 
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I ^ ^ I g ^ I g ^ ^ ^ 1 
i _ _ _ 
Gain setting 22 11 j J ] j ^ 
Rate unit 439 4 ^ 4 ^ " J ^ 
Gain setting 33 22 55"° ‘ 五 
Rate unit Y m [ ^ f ^ ^ 
Gain setting 44 ^ ~ ° ^ 33 ^^ 
Rate unit ES ES ~ ‘ ^ g ^ 
ES = excess scatter 
Table 4.1: Variation in rate signal with change in gain setting for IgG subclass assays 
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IgGl lgG2 IgG3 5 ^ 
Mean j^^I 3 ^ j ^ j ^ 
Low ^ 7 4 ^ i f 
cv (o/o) 0：^ L4" ^ r ^ 
Mean 3 ^ 5^ 37l 面 
Intermediate SD 48 64 “ 6 ~^ 
CV (%) L4" L2 L5 L ^ 
Mean 6050 6729 ^ 4 ^ 
High ~SD r i 3 ^ T~ T 
CV (%) r ^ L2 L3 ^ 
A11N = 20 
Table 4.2: Within batch precision at three levels of IgG subclass concentrations 
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IgGl IgG2 IgG3 1 ^ 
Mean 1400 ^ j ^ j ^ 
Low " § 5 ^ S 6 3~ 
CV (%) Z \ ^ ^ ^ ^ 
Mean 1 ^ U ^ m j ^ 
Intermediate SD 27 ^1 " 4 ~ ~ ^ 
CV (%) L4 ^ L8 ^ 
M ^ mA 诵 ^ ‘ ^ 
High ~SD ^ U8 7 n " 
CV (%) I I 4 3 ^ ^ 
N = 10 for IgGl, IgG3 and IgG4 ‘ 
N = 7 for IgG2 
Table 4.3: Inter-assay precision at three levels of IgG subclass concentrations 
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IgGl IgG2 IgG3 ^ G 4 " 
Original V m vTs ^ f ^ " 
[Hb] 500 mg/dL H 5 l m §1 f 7 ^ 
% interference 1 2 1 ^ ' Z^ 
Table 4.4: Effect ofhaemolysis on IgG subclass assays. 
IgGl IgG2 IgG3 5 ^ 
Original 1284 1049 T 5 i ^ ^ 
Triglycerides 1305 1031 ] ^ ^ 
(2Q0mg/dL) 
% negative -2 2 n J ^ 
interference 
° Original F277 °"^1036 ° I i o ° ~ ~ ^ 
Triglycerides 1256 1001 f ^ y ^ 
(4Q0mg/dL) 
% negative “ 
interference ^J ^ 27 100 
UR = unstable reaction 
Table 4.5: Effect of lipaemia on IgG subclass assays. 
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IgGl IgG2 IgG3 1 ^ 
Recovered 7727 3213 ^ 1396 271 
Expected 8033 3340 f ^ f f T 
% recovery 96.2 96.2 100.4 9 9 X 
~ ~ = * = H = ^ ~ ^ ~ " h = = = = ] = = — = » = 4 = = = = 
Recovered 8022 3966 1402 1 ^ 
Expected 8266 3 4 ^ H l 2 2 ^ 
% recovery 97.0 114.6 9 ^ 101.4 
Recovered 2610 2051 298 °^^JTT 
Expected 2614 2076 3 ^ f ^ 
0/0 recovery 99.8 ^ ^ j ^ j y 
Recovered 2776 2065 = 323 7 ^ 
Expected 2847 2 l % 324 T ^ 
% recovery 97.5 94.0 9 ^ io0.6 
Table 4.6: Results for recovery experiment of IgG subclass assays 
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CHAPTER 5 
RESULTS II: IgG Subclass 
Deficiency in Hong Kong 
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5.1 IgG subclass concentrations and humoral immune status evaluation 
results of patients and control subjects 
All the test results are tabulated on Table 5.1. 
5.2 Statistical tests 
Results of Mann Whitney U test on IgG subclass concentrations of adult patient and 
control groups are shown on Table 5.2 and Whisker plots (Figures 5.1-5.4) 
Result of Mann Whitney U test on IgG2 concentration of adult patients suffering 
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Figure 5.1: IgGl: Patients and Controls Distribution 
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Figure 5.3: IgG3: Patients and Controls Distribution 
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DISCUSSION I: The Binding 
Site IgG Subclass Array Kit 
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6.1 IgG subclass assays 
The IgG subclass assay is based on the principle of rate nephelometry. Antigens and 
antibodies are mixed together in the presence of ethylene glycol, a reagent, which 
enhance the lattice formation of the immune complex. The maximum rate of change 
of the scattering signal is proportional to the antigen concentration. 
6.2 Within batch and inter-assay precision 
The within batch and inter-assay precisions as shown on Tables 4.2 and 4.3 are 
comparable with that given in the package insert. The CV values ranges from the 
lowest of 0.6% to the highest of 1.9% for within batch precision and from 1.4% to 
4.3% for inter-assay precision. All within batch and inter-assay CV are comparable 
with that quoted by The Binding Site. 
6.3 Lowest limit of detection 
The lowest limit of detection is defined as the point in which the curve constructed 
by doubling dilutions of a high sample deviates from linearity. In order to eliminate 
the source of human error in fitting the curve for linearity, the lowest limit of 
detection was taken as the intersection point of line ofbest fit connecting the top four 
samples for linearity assay with the best fit lines connecting the lower six samples. 
The results so obtained are comparable with that claimed by The Binding Site. 
The effective lowest limit of detection for IgG3 and IgG4 are the same as that 
determined experimentally. For IgGl and IgG2, the effective lowest limit of 
detection can be lowered to a level 36 times and 6 times less than that determined 
experimentally. The rationale behind this is that for these two assays, samples of 
very low values can be assayed using a sample 36 times more concentrated and six 
time more concentrated than the standard dilutions of 1:216 and 1:36 respectively for 
IgGl and IgG2 thereby lowering the limit of detection. Li the IgG subclass assays, 
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the lowest possible sample dilution that can be used is 1:6; neat serum sample is 
never used owing to the fact that if the matrix of a neat sample creates a high lower 
signal to noise ratio and hence the assay will lost sensitivity. 
6.4 Interference 
biterference experiments were carried out as described in section 2.2.3.5 
Haemolysed sample at a haemoglobin concentration of 500 mg/dL did not 
significantly affect the results of IgGl and IgG2 assays. For both IgG3 and IgG4, 
which were assayed at a dilution of 1:6, a slight negative interference was observed. 
Lipaemia, arising as a result of light scattering molecules in serum, will definitely 
affect an assay using nephelometry in which the scattering of light is used as the 
parameter of quantification. As expected, degree of interference varied with the 
dilution of the serum sample used. At a dilution of 1:6 for IgG3 and IgG4, 
significant negative interference on the result was observed at a triglycerides 
concentration of 200mg/dL. At 400mg/dL, the assay for IgG4 returned as unstable 
reaction while IgG3 suffered a negative interference of 27%. On the other hands, 
lipaemia at 400 mg/dL did not significantly affect the performance o f IgGl and IgG2 
at the standard dilution used for analysing these two subclasses, i.e. at 1:216 and 
1:36. However, it can be projected from the performance o f IgG3 and IgG4 that if 
the IgGl and IgG2 are to be assayed at smaller dilutions as in the case ofsample with 
low subclass values, the same phenomenon of interference would be observed. 
6.5 Recovery of IgG 
As shown on table, the recovery ranges s from 96% to 114.6% and unfortunately, the 
lowest and highest recovery were with IgG2 subclass assay at a high level. There is 
no logical explanation for this observation and warrants further investigation. 
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6.6 Overall performance of the nephelometric assay 
The IgG subclass assay on the Array 360 protein system can be easily setup. 
Familiarisation takes less than half an hour on an individual already trained to 
operate on the analyser. Array 360 has an additional capability of storing not only 
test combination but also sample dilutions in its panel definition. This feature is 
made use of in defining panels for calibration. 
The user prepared chemistries used dedicated optic on the Array 360 analyser thus 
allowing easy trouble shooting of an assay when the performance was poor. The 
nephelometric assay for IgG subclass was fast to perform. Results were generated at 
less than 3 minutes per sample of 4 subclasses by using the left and right optic 
simultaneously. Together with the enhanced reproducibility of an automated assay, 
the IgG subclass should be a method of choice for provision ofservice. 
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CHAPTER 7 
DISCUSSION II: IgG Subclass 
Deficiency in Hong Kong 
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7.1 IgG subclass deficiency in adults 
As described in section 3.1, thirty-one specimens from 29 adult patients (2 patients 
contributed two pair of samples in two different episodes) were compared with 23 
adult controls. Statistical test by Mann-Whitney U test detected no significance 
difference between the patient group and the control group for IgG2 and IgG4 
concentrations. IgGl and IgG3 displayed significant differences between the patient 
group and control group. However, the differences between the two groups were 
such that the patient group has higher IgGl and IgG3 concentrations than the control 
group as shown by Figures 5.1 and 5.3. 
In the context of IgG deficiency, the 29 patients studied were not deficient 
statistically. The patient group included patients with recurrent infections. The 
significantly higher concentrations o f I g G l and IgG3 could be explained by the fact 
that these patients are not IgG subclass deficient. They can mount an immune 
response to infections and their higher concentrations of IgGl and IgG4 subclasses 
would not be surprising. 
In this pilot study, resources have not been available for setting up of a reference 
interval for the four IgG subclasses. This is especially true for the pediatric reference 
intervals, which are divided into groups of 2 to 3 years' intervals. Though Mann 
Whitney U test revealed no difference in the between the patient group and control 
group, an attempt was made to study individual patients with respect to the reference 
intervals quoted by The Binding Site which are based on populations in the 
Birmingham area, United Kingdom. The Binding Site reference intervals quoted 
include the mean and the 95 percentile range. In the comparisons that follow, 
individual IgG subclass concentrations are examined if it falls below the mean or 2 
times the lower 2.5 percentile value whichever the lower. 
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A review of the IgGl and IgG4 results of the studied adult patient group revealed no 
single results for these two subclasses fall lower than the criteria. For the control 
subjects, two females displayed IgGl concentrations 5139 and 5391 mg/L 
respectively. These values fall short of the reference point by less than 15%. The 
mean o f the IgG subclass The Binding Site IgGl reference intervals demonstrated a 
bias toward the lower percentiles. It would therefore be reasonable to assume that 
these two results could well not be clinically significant. 
IgG2 concentrations o f t h e entire control group are higher than the reference point 
for further examination. Two female patients however have concentrations below 
the reference point, one of them by 10 mg/L and were considered unremarkable. The 
second result was from a patient diagnosed of IgA and IgG2 deficiency. Her IgG2 
level of 1728 mg/L was still within the 95% range o f t h e quoted reference range. 
Whether this is a case of genuine IgG2 deficiency or jus t sub-normal level o f IgG2 
warrants more thorough investigations after a proper reference interval for local 
population is setup. 
Two patients and 5 control subjects have IgG3 levels lower than the set reference 
point. One of the 5 control subjects has an IgG3 level o f l 7 2 mg/L, which was out of 
the 95 percentile range. One patient was diagnosed ofrecurrent methicillin resistant 
Staphylococcus aureus infection. His IgG3 level was 15% lower than the reference 
point. Again the significance of this requires further investigations. 
Nearly 80% of the adult patients studied suffered from bronchiectasis, which is 
defined as chronic dilatation of one or more bronchi [13]. De Gracia et al. [47] 
observed 39 abnormal low IgG2, IgG3 and IgG4 values among 31 out o f 6 5 patients 
with bronchiectasis of no known cause. This is especially true of IgG2 deficiency 
which accounts for 25 of the 39 abnormal low IgG subclass results. Mann Whitney 
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U test on the IgG2 concentrations of our bronchiectasis patient group with our 
control group demonstrated no significance difference (p=0.16). 
7.2 Paediatric patients 
Based on the same reference point criteria, IgG subclass concentration ofpaediatric 
patients enrolled in the study was compared with The Binding Site paediatric 
reference intervals. 
There was one patient with all four subclass concentrations in the review range. The 
concentrations are however still within the reference interval for Birmingham 
paediatric population. This patient also presented with a total IgM of0 .1 g/L, IgA of 
<0.07 g/L and IgG of 4.7 g/L. He at the age of 17 would be expected to have a 
mature immune system. These low values strongly suggest immunodeficiency of 
some kind. Whether the panhypogammaglobulinaemia is of primary origin or 
secondary to other causes definite needs further investigations. 
Other than the one patient discussed above, paediatric IgG2, IgG3 and IgG4 
concentrations are all in the unremarkable range. Three values of IgGl between 
5000 mg/L to 6000 mg/L interval fulfil the criteria for further evaluation, hi view of 
The significance of these results are doubtful. They are selected out as a result ofour 
caution in selecting of review criteria in the absence of a control group and local 
reference interval. 
7.3 Recurrent infections and IgG subclass deficiency 
There is a whole spectrum of causes to recurrent respiratory tract infections other 
than IgG subclass deficiency. Any diseases that compromise the patients' lung 
fUnction in predispose patients to recurrent pulmonary infection, tuberculosis being 
the commoner example. The negative finding in our group o f 5 3 patients is therfore 
not difficult to explain. Furthermore, another cause of recurrent infections was not 
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studied in this patient group, namely, specific antibody deficiency that can be present 
in the absence of an IgG subclass deficiency. 
7.4 Summary 
to the current study, no IgG subclass deficiency case was identified out of the 53 
patients enrolled. The clinical usefulness of the assays however should not be 
undermined. In order to obtain a better perspective on the situation in Hong Kong, a 
survey into the prevalence of IgG subclass deficiency should be conducted. 
IgG subclass deficiency is an easy disorder to manage once identified. The efficacy 
ofimmunoglobulin replacement therapy had been reported [18]. 
The IgG subclass assays evaluated in this study is easy to perform and reliable. 
However, from a budgetary resource point ofview, the assay is costly. Reagent cost 
per panel of four subclasses amount to HK$200 let alone the cost in reagents 
consumed for calibration and controls. 
In conclusion, the IgG subclass assay should be make available since effective 
treatment is available once diagnosed. Mravenous immunoglobulin replacement 
therapy though not without risk but improve the quality of life o f t h e patients and 
recover large number of productive hours as the severity of recurrent infections 
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